Celanese Corp. Q1 2007 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007. Celanese Corporation is an integrated global hybrid chemical company producing value-added chemicals, thermoplastic polymers, and other chemical-based products. The company operates through four primary segments: Chemical Products, Technical Polymers (Ticona), Acetate Products, and Performance Products. The filing includes a revision to the 2006 consolidated statement of shareholders' equity to correctly present the adoption impact of FASB Statement No. 158.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Sales | $1,631 million | $1,498 million |
| Gross Profit | $391 million (24.0% margin) | $338 million (22.6% margin) |
| Operating Profit | $239 million | $169 million |
| Net Earnings | $201 million | $117 million |
| Diluted EPS (Total) | $1.15 | $0.68 |
| Cash and Equivalents | $1,115 million | $312 million (Q1 2006) |
| Total Debt | $3,489 million | $3,498 million (Dec 31, 2006) |
| Operating Cash Flow | $12 million | ($1 million) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% year-over-year, driven by a 3% price increase, 1% volume increase, and 3% favorable currency impacts. The Acetate Products segment saw a 34% sales increase largely due to the acquisition of Acetate Products Limited (APL).
- Profitability: Operating profit rose 41% to $239 million, fueled by higher volumes, pricing, and a $22 million reduction in SG&A expenses (excluding one-time severance and legal costs present in Q1 2006).
- Discontinued Operations: The company recognized a $31 million pre-tax gain from the sale of its oxo products and derivatives businesses (completed Feb 28, 2007). Total earnings from discontinued operations were $57 million compared to $21 million in Q1 2006.
- Acquisitions: Completed the acquisition of APL for approximately $112 million plus $7 million in direct costs.
Guidance, Outlook, and Risks
- Debt Refinancing: In April 2007 (subsequent to the period end), the company completed a comprehensive recapitalization. This included a new senior credit agreement ($2.28 billion USD and €400 million Euro term loans) and tender offers that retired significant portions of Senior Subordinated and Senior Discount Notes. The company expects to incur $215–$225 million in interest expense related to tender costs in Q2 2007.
- Share Repurchases: In April 2007, the company repurchased approximately 2.35 million shares of Series A common stock for $72 million.
- Legal and Contingencies:
- Sorbates Antitrust: Accruals of $151 million remain for antitrust matters; estimated additional future losses range from $0 to $9 million.
- Plumbing Actions: Remaining accruals of $66 million for product liability claims.
- Domination Agreement: Legal challenges regarding the CAG Domination Agreement remain pending in German courts, which could potentially require reversal of actions or compensation payments.
- Environmental: Environmental reserves totaled $123 million as of March 31, 2007.
Investor Verification Checklist
- Refinancing Impact: Verify the actual Q2 2007 interest expense related to the $215–$225 million in tender costs and unamortized financing fees.
- Discontinued Operations: Confirm the final working capital adjustments to the $31 million gain on the sale of the oxo products business.
- Legal Reserves: Monitor the status of the Sorbates antitrust proceedings and the CAG Domination Agreement litigation for potential changes in accruals.
- Segment Performance: Review the sustainability of the 34% sales growth in the Acetate Products segment post-APL acquisition.
- Variable Rate Debt: Assess exposure to interest rate fluctuations on the remaining unhedged variable rate debt (approx. $715 million USD and €340 million).